{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:54:09Z","timestamp":1788537249582,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jocn.2021.05.052","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T06:00:45Z","timestamp":1623304845000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Autoimmune encephalitis in a tertiary hospital in the Philippines"],"prefix":"10.1016","volume":"90","author":[{"given":"Nikolai Gil D.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian I.","family":"Espiritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerson F.","family":"Agabao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Emmanuel E.","family":"Abejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea Angela M.","family":"Salonga-Quimpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor I.","family":"Cabral-Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Dominic G.","family":"Jamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Leonard R.","family":"Pascual V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Laurence L.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina Tanya P.","family":"Gosiengfiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2021.05.052_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/0004-282x20170176","article-title":"Autoimmune encephalitis: a review of diagnosis and treatment","volume":"76","author":"Dutra","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jocn.2021.05.052_b0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Dalmau","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2021.05.052_b0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13311-015-0410-6","article-title":"Antibody-mediated autoimmune encephalopathies and immunotherapies","volume":"13","author":"Gastaldi","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jocn.2021.05.052_b0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2021.05.052_b0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jocn.2021.05.052_b0030","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2021.05.052_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.05.052_b0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00415-015-7781-9","article-title":"Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis","volume":"262","author":"Zekeridou","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0045","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.05.052_b0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jocn.2021.05.052_b0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jocn.2021.05.052_b0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s40674-018-0089-z","article-title":"An update on the treatment of pediatric autoimmune encephalitis","volume":"4","author":"Stingl","year":"2018","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.1016\/j.jocn.2021.05.052_b0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in Korea: Clinical features, treatment, and outcome","volume":"10","author":"Lim","year":"2014","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2016.04.004","article-title":"Antibody-mediated autoimmune encephalitis in childhood","volume":"60","author":"Brenton","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.braindev.2018.02.005","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in children: incidence and experience in Hong Kong","volume":"40","author":"Ho","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.jocn.2021.05.052_b0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient characteristics and outcome associations in AMPA receptor encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","article-title":"Autoimmune encephalitis in children","volume":"30","author":"Dale","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14737159.2018.1431124","article-title":"N-methyl-D-aspartate receptor encephalitis: Laboratory diagnostics and comparative clinical features in adults and children","volume":"18","author":"Gastaldi","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jocn.2021.05.052_b0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neurol.2018.07.006","article-title":"Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jocn.2021.05.052_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","article-title":"Imaging of autoimmune encephalitis \u2013 Relevance for clinical practice and hippocampal function","volume":"309","author":"Heine","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jocn.2021.05.052_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune encephalitis\u2014A systematic analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.05.052_b0135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: Clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0145","first-page":"1","article-title":"Clinical and electroencephalographic features of the seizures in neuronal surface antibody-associated autoimmune encephalitis","volume":"11","author":"Wang","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1550059415595907","article-title":"Are there any specific EEG findings in autoimmune epilepsies?","volume":"47","author":"Baysal-Kirac","year":"2016","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.jocn.2021.05.052_b0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","article-title":"Electroclinical features of seizures associated with autoimmune encephalitis","volume":"60","author":"Steriade","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2021.05.052_b0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/dmcn.12647","article-title":"The recognition and treatment of autoimmune epilepsy in children","volume":"57","author":"Suleiman","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jocn.2021.05.052_b0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2021.05.052_b0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000130","article-title":"Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome","volume":"2","author":"Byrne","year":"2015","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jocn.2021.05.052_b0175","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2019","journal-title":"Neurol \u2013 Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jocn.2021.05.052_b0180","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.05.052_b0185","first-page":"185","article-title":"Voltage-gated potassium channel\u2013complex autoimmunity and associated clinical syndromes","author":"Irani","year":"2016","journal-title":"Handb Clin Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:27:54Z","timestamp":1760822874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"alternative-id":["S0967586821002708"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.05.052","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune encephalitis in a tertiary hospital in the Philippines","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}